Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Gene expression profiling of peripheral blood cells for early detection of breast cancer

Jørgen Aarøe, Torbjørn Lindahl, Vanessa Dumeaux, Solve Sæbø, Derek Tobin, Nina Hagen, Per Skaane, Anders Lönneborg, Praveen Sharma and Anne-Lise Børresen-Dale*

Breast Cancer Research 2010, 12:R7 doi:10.1186/bcr2472

Accesses  

  • Last 30 days: 161 accesses
  • Last 365 days: 1704 accesses
  • All time: 6866 accesses

Cited by

BioMed Central: 4 citations

Research article   Open Access Highly Accessed

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls

Mikkel Noerholm, Leonora Balaj, Tobias Limperg, Afshin Salehi, Lin Zhu, Fred H Hochberg, Xandra O Breakefield, Bob S Carter, Johan Skog BMC Cancer 2012, 12:22 (17 January 2012)

Research article   Open Access

Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)

Eric Tram, Irada Ibrahim-zada, Laurent Briollais, Julia A Knight, Irene L Andrulis, Hilmi Ozcelik Breast Cancer Research 2011, 13:R77 (11 August 2011)

Research article   Open Access

Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors

Heather G LaBreche, Joseph R Nevins, Erich Huang BMC Medical Genomics 2011, 4:61 (22 July 2011)

A human breast cancer predictor generated from transcriptome patterns in transgenic mouse tumor model peripheral blood samples serves as a proof-of-concept for using animal models to develop genomic biomarkers.

Review   Open Access Highly Accessed

Assessing the human immune system through blood transcriptomics

Damien Chaussabel, Virginia Pascual, Jacques Banchereau BMC Biology 2010, 8:84 (1 July 2010)

This article is part of a collection on Hope of progress

Chaussabel and colleagues review the contributions of blood transcriptomics to identifying therapeutically relevant signatures of autoimmune and infectious disease, and the challenges of developing this approach into a mainstream tool.